EVENT

Crinetics Positive Initial Findings from Ongoing Open-Label Phase 2 Study of Paltusotine for the Treatment of Carcinoid Syndrome

December 18, 2023

Event Details

Start Date: December 18, 2023 — 5:00 PM ET

End Date: December 18, 2023 — 6:00 PM ET

WEBCAST

PRESENTATION

Crinetics will hold a conference call and live webcast on Monday, December 18 at 5:00 p.m. Eastern Time to discuss the initial findings from the Phase 2 study.

Listen To Webcast

Transforming Endocrine Disease Treatment

Be the first to know about the advances we're making in endocrine care.

EVENT

Crinetics Positive Initial Findings from Ongoing Open-Label Phase 2 Study of Paltusotine for the Treatment of Carcinoid Syndrome

Event Details

Transforming Endocrine Disease Treatment

Email Signup